
IDEXX Laboratories (IDXX) Stock Forecast & Price Target
IDEXX Laboratories (IDXX) Analyst Ratings
Bulls say
IDEXX Laboratories is a top-performing company in the animal health industry with a global presence and a diverse product portfolio including diagnostic test kits, lab services, and software solutions. The company has consistently achieved strong financial results with double-digit EPS growth and is well-positioned to benefit from the growing trend of "humanization of pets". While there are potential risks, such as negative media attention, the company's CEO transition and new product launches are expected to drive further growth. Additionally, the industry itself is expected to rebound, which could further boost IDEXX's performance.
Bears say
IDEXX Laboratories is a company with a strong product line and high recurring revenue, specifically in its core companion animal group segment, which represents 90% of its total revenue. While the animal health industry has significant growth potential, IDXX may face challenges such as potential supply chain disruptions and government regulations. However, with its market leadership and investments in research and development, IDXX is well-positioned for long-term secular growth.
This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.
IDEXX Laboratories (IDXX) Analyst Forecast & Price Prediction
Start investing in IDEXX Laboratories (IDXX)
Order type
Buy in
Order amount
Est. shares
0 shares